1 Final Shot for Hyped Alzheimer's Drug + MORE

As the summer travel season got underway, Southwest Airlines (NYSE: UAL) saw sizable swings in short interest. Other players in the U.S. airline industry that saw increasing short interest between the June 14 and June 28 settlement dates include JetBlue Airways (NASDAQ: LCC).But the number of shares sold short during the period in Allegiant Travel (NASDAQ: ALK) and Delta Air Lines (NYSE: DAL) declined…

Continue Reading On investopedia »

This thread is now in the Personal Consumer Issues forum (cars).

Continue Reading On bogleheads.org »

Rails might begin using natural gas, but this one could profit from higher prices of the commodity.    

Continue Reading On fool.com »

By SA Editor Miriam Metzinger: Stocks discussed on the Lightning Round segment of Jim Cramer’s Mad Money Program, Friday July 12.Bullish Calls:
Zynga (ZNGA), Nokia (NOK): “In terms of speculation, I like Nokia and Zynga.”
Bearish Calls:
BHP Billiton (BHP): “BHP Billiton is going to keep coming down if the Chinese economy doesn’t get stronger…

Continue Reading On seekingalpha.com »

Filed under: Investing

Alzheimer’s disease has been incredibly frustrating for the pharmaceutical industry. Decades of R&D have left little to show for the time and money spent. Designing successful treatments for a $600 billion worldwide problem (including dementia) is difficult when scientists don’t totally understand what causes it…

Continue Reading On dailyfinance.com »